CR8053A - Alquil-estra-1,3,5(10)- trienos 8beta-vinil- 11beta-(omega- sustituidos) - Google Patents

Alquil-estra-1,3,5(10)- trienos 8beta-vinil- 11beta-(omega- sustituidos)

Info

Publication number
CR8053A
CR8053A CR8053A CR8053A CR8053A CR 8053 A CR8053 A CR 8053A CR 8053 A CR8053 A CR 8053A CR 8053 A CR8053 A CR 8053A CR 8053 A CR8053 A CR 8053A
Authority
CR
Costa Rica
Prior art keywords
trienos
vinil
8beta
11beta
estra
Prior art date
Application number
CR8053A
Other languages
English (en)
Inventor
Brauer Nico
Peters Olaf
Hillisch Alexander
Bohlmann Rolf
Richter Margit
Peter Muhn Hans
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CR8053A publication Critical patent/CR8053A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Se refiere a ALQUIL-ESTRA-1,3,5(10)- TRIENOS 8BETA-VINIL- 11BETA-(OMEGA- SUSTITUIDOS) con actividad antagonista de ERBeta, a procedimientos para su preparacion , a sus productos intermediarios, a preparados farmaceuticos que contienen los compuestos segun la invencion, asi como su uso para la preparacion de medicamentos
CR8053A 2003-04-22 2005-10-21 Alquil-estra-1,3,5(10)- trienos 8beta-vinil- 11beta-(omega- sustituidos) CR8053A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10318896A DE10318896A1 (de) 2003-04-22 2003-04-22 8beta-Vinyl-11beta-(omega-substituierte)alkyl-estra-1,3,5(10)-triene

Publications (1)

Publication Number Publication Date
CR8053A true CR8053A (es) 2006-05-29

Family

ID=33304956

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8053A CR8053A (es) 2003-04-22 2005-10-21 Alquil-estra-1,3,5(10)- trienos 8beta-vinil- 11beta-(omega- sustituidos)

Country Status (21)

Country Link
US (1) US7375098B2 (es)
EP (1) EP1622924A2 (es)
JP (1) JP2006524202A (es)
KR (1) KR20060005386A (es)
CN (1) CN100381457C (es)
AR (1) AR044056A1 (es)
AU (1) AU2004232462A1 (es)
BR (1) BRPI0409794A (es)
CA (1) CA2522354A1 (es)
CL (1) CL2004000856A1 (es)
CR (1) CR8053A (es)
DE (1) DE10318896A1 (es)
EA (1) EA009606B1 (es)
EC (1) ECSP056180A (es)
MX (1) MXPA05011386A (es)
NO (1) NO20055493L (es)
PE (1) PE20050423A1 (es)
RS (1) RS20050793A (es)
UY (1) UY28284A1 (es)
WO (1) WO2004094451A2 (es)
ZA (1) ZA200509447B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152248A0 (en) * 2000-04-12 2003-05-29 Schering Ag 8beta-HYDROCARBYL-SUBSTITUTED ESTRATRIENES FOR USE AS SELECTIVE ESTROGENS
CA2578164A1 (en) 2004-09-07 2006-03-16 Wyeth 6h-[1]benzopyrano[4,3-b]quinolines and their use as estrogenic agents
CA2619476A1 (en) * 2005-10-05 2007-04-19 Sicor Inc. Separation of fulvestrant isomers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1226155E (pt) * 1999-11-02 2007-07-26 Bayer Schering Pharma Ag 18-nor-esteróides como estrogénios selectivamente activos
IL152248A0 (en) * 2000-04-12 2003-05-29 Schering Ag 8beta-HYDROCARBYL-SUBSTITUTED ESTRATRIENES FOR USE AS SELECTIVE ESTROGENS
DE10151114A1 (de) * 2001-10-15 2003-04-17 Schering Ag 8ß-Substituierte-11ß-aryl-estra-2,3,5(10)-trienderivate

Also Published As

Publication number Publication date
US20050065135A1 (en) 2005-03-24
WO2004094451A2 (de) 2004-11-04
ECSP056180A (es) 2006-04-19
NO20055493L (no) 2006-01-18
JP2006524202A (ja) 2006-10-26
CL2004000856A1 (es) 2005-03-28
ZA200509447B (en) 2009-08-26
CA2522354A1 (en) 2004-11-04
CN100381457C (zh) 2008-04-16
US7375098B2 (en) 2008-05-20
DE10318896A1 (de) 2004-11-25
CN1777618A (zh) 2006-05-24
BRPI0409794A (pt) 2006-05-30
EA200501568A1 (ru) 2006-06-30
RS20050793A (sr) 2008-04-04
MXPA05011386A (es) 2006-04-18
AR044056A1 (es) 2005-08-24
KR20060005386A (ko) 2006-01-17
EP1622924A2 (de) 2006-02-08
UY28284A1 (es) 2004-11-30
AU2004232462A1 (en) 2004-11-04
EA009606B1 (ru) 2008-02-28
PE20050423A1 (es) 2005-08-13
NO20055493D0 (no) 2005-11-21
WO2004094451A3 (de) 2004-12-23

Similar Documents

Publication Publication Date Title
CU23415B7 (es) Derivados de 2,6- quinolinilo y 2,6- naftilo, procesos para su preparación y sus usos
PA8582801A1 (es) Nuevos derivados espirotricíclicos y su uso como inhibidores de la fosfodiesterasa
PA8592301A1 (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos
SV2002000249A (es) Derivados de tiazolilamida ref, lea 34082-sv
UY28342A1 (es) Nuevos compuestos
GT200500007A (es) [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia.
PA8577001A1 (es) Benzoilureas heterociclicamente sustituidas, procedimiento para su preparacion y su uso como farmacos
CR10778A (es) Derivados de sulfonil-fenil-2h-[1,2,4]oxadiaxol-5-ona, procedimientos para su preparacion y su uso como agentes farmaceuticos
AR028948A1 (es) Compuestos novedosos
ECSP099327A (es) Nuevos derivados de 1,4-benzotiepina-1,1-dióxido sustituidos con radicales bencilo, método para su preparación, productos farmacéuticos que comprenden estos compuestos y su uso
HN2002000300A (es) Nuevos derivados de piperazina
UY28572A1 (es) Compuestos novedosos
ECSP077271A (es) Derivados de pirimidina
UY28348A1 (es) Compuestos novedosos
ECSP077259A (es) Derivados de pirimidina
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
PA8542601A1 (es) Bifenilcarboxamidas reductoras de lipidos
AR029795A1 (es) Derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico sustituidos, procedimientos para su preparacion, su uso para la preparacion de medicamentos y medicamentos que contienen estos compuestos
HN2001000235A (es) Derivados puentes de piperazina
UY29818A1 (es) Nuevos compuestos de azetidina, composiciones farmaceuticas que los contienen, procesos de preparacion y sus usos terapeuticos
ECSP034754A (es) Derivados de beta-carbolina y su uso farmaceutico contra depresion y ansiedad
AR028947A1 (es) Compuestos novedosos
ES2189072T3 (es) Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SV2007002315A (es) Derivados de octahidropirrolo[3,4-c]pirrol ref. pc32623a
CR8053A (es) Alquil-estra-1,3,5(10)- trienos 8beta-vinil- 11beta-(omega- sustituidos)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)